Keerthy Sunder, MD

Chief Medical Officer at Karma Doctors & Associates

Keerthy Sunder, MD has extensive work experience in the field of healthcare and neuroscience. Keerthy is currently serving as the Chief Medical Officer at Karma Doctors & Associates since 2021. In addition, they hold the position of Medical Director at Karma TMS since 2022. Previously, Dr Sunder worked as a Scientific Advisor at Solace Lifesciences NuCalm, where they contributed to the development of neuroscience technologies to combat stress. Keerthy also founded Tune My Brain in 2019, a platform that focuses on optimizing brain performance through smart nutraceuticals. Dr Sunder has been an Adjunct Professor at Southern California University of Health Sciences since 2019 and an Assistant Clinical Professor at the University of California, Riverside School of Medicine since 2017. Keerthy is a member of the Credentialing Committee at the American Board of Addiction Medicine and an Advisory Board Member at NAMI California. Prior to their current roles, Dr Sunder served as a Principal Investigator for CNS Clinical Trials at CITrials from 2011 to 2019.

Keerthy Sunder, MD attended the University of Pittsburgh School of Medicine, where they obtained their MD degree. Their field of study encompassed Addiction Medicine, Psychiatry, Women's Health, and Clinical Research. Additionally, they hold multiple certifications, including being Board Certified in Psychiatry by the American Board of Psychiatry and Neurology, Inc. Keerthy is also a Board Certified Addiction Specialist certified by the American Board of Addiction Medicine (ABAM). Keerthy Sunder is further certified in Obstetrics and Gynecology by the Royal College of Obstetricians and Gynaecologists (RCOG). Furthermore, they are a Certified Menopause Practitioner accredited by The North American Menopause Society. Lastly, they have received certification in Neuronetics TMS Therapy from Neurostar University. No specific dates were provided for the acquisition of these certifications.

Links

Timeline

  • Chief Medical Officer

    January, 2021 - present